HelixNano

Using mRNA to modify biology at the push of a button

First Investment: 2017

HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.

Explore Companies

Mesa Quantum

Chip-scale quantum sensors for industry

Regent

Building all-electric vehicles for fast, safe, clean coastal transportation

Emerald AI

Overcoming growth bottlenecks in the AI industry by making data centers more power-flexible

Callosum

Orchestration software for an era of multimodal, not monolithic, artificial intelligence